Navigation Links
Scientists Gain Insight Into Blood Cancer's Progression
Date:2/20/2009

Findings for chronic myeloid leukemia may have wider implications, researchers say

FRIDAY, Feb. 20 (HealthDay News) -- U.S. researchers say they've spotted a mechanism by which chronic myeloid leukemia (CML) progresses into a deadlier stage.

The finding may improve patient outcomes, they said.

The researchers found that when a molecular off-switch called glycogen synthase kinase (GSK) 3 beta becomes faulty in chronic stage CML cells, it fails to turn off another protein called beta-catenin. This enables pre-leukemia stem cells to develop into leukemia stem cells and increase their numbers, leading to the more dangerous "blast crisis" state of CML.

"If we can predict when a patient is moving from the chronic phase in CML to the blast crisis stage, then we can hopefully intervene before it's too late," study co-leader Dr. Catriona H.M. Jamieson, an assistant professor of medicine at the University of California, San Diego (UCSD) School of Medicine and director for Stem Cell Research at the Moores UCSD Cancer Center, said in a university news release.

Faulty GSK 3 beta also offers a potential treatment target, the researchers said. "This knowledge may enable us to design and develop more effective, personalized therapies for these patients," co-first author and staff research associate Annelie Abrahamsson said in the news release.

The study appears online in this week's issue of the Proceedings of the National Academy of Sciences.

The findings may not be limited to CML, the team noted.

"Downregulating beta-catenin and GSK deregulation may have other implications in many cancers," Jamieson said. "By studying CML, we can understand the molecular evolution of disease and the stepwise progression to cancer. It becomes a useful paradigm for understanding how cancers evolve and the pathways that are essential to escape the normal control mechanisms."

More information

The U.S. National Cancer Institute has more about chronic myeloid leukemia.



-- Robert Preidt



SOURCE: University of California, San Diego, news release, Feb. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems
2. Two Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimers Disease
3. University of Ottawa Heart Institute Scientists Unlock Mechanism That Turns on Weight-Loss Gene
4. Scientists uncover secrets of potential bioterror virus
5. Scientists uncover indicator that warns leukemia is progressing to more dangerous form
6. In Month of the Heart, Scientists Identify Better Way to Predict Heart-Disease Risk
7. Scientists Heartened at Prospect of End to Stem Cell Ban
8. Scientists discover key factor in controlling the breakdown of bone
9. Team led by Scripps Scientists increases understanding of two types of blindness
10. CSHL scientists discover link between control of chromosome duplication and segregation
11. UCSB scientists make headway in understanding Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Gain Insight Into Blood Cancer's Progression
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery ... Arizona pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic ... , Dr. Olson says the decision to support the pageant in an ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based ... however, are unsure how to move forward, given the need to sustain current ... forward tailored to an organization’s specific needs. , PYA Principal Martie Ross states, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: